A detailed history of Aquatic Capital Management LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Aquatic Capital Management LLC holds 4,900 shares of MYGN stock, worth $122,255. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,900
Holding current value
$122,255
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$17.59 - $23.59 $86,191 - $115,591
4,900 New
4,900 $104,000
Q3 2023

Nov 14, 2023

BUY
$15.99 - $23.22 $83,148 - $120,744
5,200 New
5,200 $83,000
Q1 2023

May 15, 2023

SELL
$15.26 - $23.75 $119,028 - $185,250
-7,800 Reduced 32.64%
16,100 $374,000
Q4 2022

Feb 14, 2023

BUY
$14.51 - $20.99 $242,317 - $350,533
16,700 Added 231.94%
23,900 $346,000
Q3 2022

Nov 14, 2022

BUY
$18.21 - $27.88 $131,112 - $200,736
7,200 New
7,200 $137,000

Others Institutions Holding MYGN

About MYRIAD GENETICS INC


  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $2.01B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.